Clinical Trials in Colorado

Showing 10701-10720 of 15,592 trials

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

NCT02398461

This is a Phase 1, multi-center, double-blind, randomized, placebo-controlled, dose-escalation study in subjects with relapsing Multiple Sclerosis (MS). The primary outcome will be the safety and tolerability of a single dose of rHIgM22 in relapsing MS subjects.

Multiple Sclerosis, Acute Relapsing

Acorda Therapeutics27 participantsStarted Apr 2015

Long Beach, California, United States • Sacramento, California, United States • San Francisco, California, United States +9 more locations

COMPLETEDPhase 448 miles

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295

New immunization recommendations in the US include vaccination of adolescents against pertussis and meningococcal disease. The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine Adsorbed) and MCV4 (Meningococcal conjugate vaccine against serotypes A, C, Y and W-135) vaccines be administered to adolescents at the same office visit if vaccination with both vaccines is indicated. Therefore, this study is designed to evaluate the safety and immunogenicity of a booster vaccination with Boostrix co-administered with Menactra as compared to the administration of either vaccine alone in healthy adolescents 11 - 18 years of age.

Acellular PertussisTetanusDiphtheria

GlaxoSmithKline1,344 participantsStarted Jan 2006

Chandler, Arizona, United States • Little Rock, Arkansas, United States • Fountain Valley, California, United States +21 more locations

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Find Trials by Condition in Colorado

The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Predicting Acute Compartment Syndrome (PACS)

SF1126 for Patients With Relapsed or Refractory Neuroblastoma

Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Trial

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Transfusion Requirements in Cardiac Surgery III

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Biomarker Assessment of Glutamatergic Target Engagement

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study

Automated Screen for Fetal Aneuploidy